Free Trial

Synopsys, Inc. $SNPS Shares Sold by King Luther Capital Management Corp

Synopsys logo with Computer and Technology background
Image from MarketBeat Media, LLC.

Key Points

  • King Luther Capital Management cut its Synopsys stake by 33.2% in the fourth quarter, selling 9,783 shares and ending with 19,676 shares worth about $9.24 million.
  • Synopsys reported better-than-expected quarterly results, with EPS of $3.35 and revenue of $2.28 billion, and it also raised FY2026 guidance to EPS of $14.72-$14.80.
  • The company has also drawn attention from analysts and investors, with several firms setting price targets near or above $600 and institutional ownership remaining high at 85.47%.
  • MarketBeat previews top five stocks to own in June.

King Luther Capital Management Corp lowered its stake in Synopsys, Inc. (NASDAQ:SNPS - Free Report) by 33.2% in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 19,676 shares of the semiconductor company's stock after selling 9,783 shares during the quarter. King Luther Capital Management Corp's holdings in Synopsys were worth $9,242,000 at the end of the most recent quarter.

Other institutional investors have also bought and sold shares of the company. Thurston Springer Miller Herd & Titak Inc. acquired a new stake in Synopsys in the fourth quarter worth about $28,000. Oakworth Capital Inc. lifted its holdings in Synopsys by 3,700.0% in the fourth quarter. Oakworth Capital Inc. now owns 76 shares of the semiconductor company's stock worth $36,000 after purchasing an additional 74 shares during the period. KERR FINANCIAL PLANNING Corp acquired a new stake in Synopsys in the third quarter worth about $38,000. N.E.W. Advisory Services LLC lifted its holdings in Synopsys by 128.6% in the fourth quarter. N.E.W. Advisory Services LLC now owns 80 shares of the semiconductor company's stock worth $38,000 after purchasing an additional 45 shares during the period. Finally, WealthCollab LLC lifted its holdings in Synopsys by 110.8% in the third quarter. WealthCollab LLC now owns 78 shares of the semiconductor company's stock worth $38,000 after purchasing an additional 41 shares during the period. Institutional investors and hedge funds own 85.47% of the company's stock.

Synopsys Price Performance

Shares of NASDAQ SNPS opened at $525.92 on Thursday. Synopsys, Inc. has a twelve month low of $376.18 and a twelve month high of $651.73. The company has a current ratio of 1.36, a quick ratio of 1.26 and a debt-to-equity ratio of 0.33. The company has a market capitalization of $100.75 billion, a price-to-earnings ratio of 81.66, a PEG ratio of 4.38 and a beta of 1.25. The firm has a 50-day moving average of $457.56 and a two-hundred day moving average of $453.69.

Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings results on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, beating analysts' consensus estimates of $3.15 by $0.20. Synopsys had a net margin of 13.76% and a return on equity of 6.83%. The company had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. During the same period in the prior year, the company earned $3.67 EPS. Synopsys's revenue was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, analysts expect that Synopsys, Inc. will post 10.28 earnings per share for the current fiscal year.

Analysts Set New Price Targets

Several research firms recently weighed in on SNPS. Citigroup upped their price objective on shares of Synopsys from $580.00 to $600.00 and gave the stock a "buy" rating in a report on Wednesday, May 13th. Berenberg Bank set a $633.00 price objective on shares of Synopsys in a report on Wednesday. HSBC downgraded shares of Synopsys from a "buy" rating to a "hold" rating and set a $455.00 price objective for the company. in a report on Friday, February 20th. The Goldman Sachs Group set a $600.00 price objective on shares of Synopsys and gave the stock a "buy" rating in a report on Wednesday, February 25th. Finally, Wells Fargo & Company upped their price objective on shares of Synopsys from $450.00 to $505.00 and gave the stock an "equal weight" rating in a report on Thursday, May 14th. Eight research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, the company presently has a consensus rating of "Hold" and an average target price of $544.88.

View Our Latest Report on Synopsys

Key Synopsys News

Here are the key news stories impacting Synopsys this week:

  • Positive Sentiment: Synopsys beat Q2 expectations, reporting non-GAAP EPS of $3.35 versus estimates around $3.17 and revenue of $2.276 billion versus consensus near $2.25 billion, showing continued demand for its chip design software. Reuters article
  • Positive Sentiment: The company raised FY2026 guidance, now projecting EPS of $14.72 to $14.80 and revenue of roughly $9.6 billion to $9.7 billion, signaling confidence in AI-driven demand and operating momentum. Press release
  • Positive Sentiment: Synopsys reached a cooperation agreement with Elliott Investment Management and added Elliott partner Jesse Cohn to its board, which could support efforts to improve margins, governance, and shareholder value. Reuters article
  • Neutral Sentiment: Despite the strong report, the stock is reacting cautiously, suggesting some investors may be taking profits after a large run-up and waiting for proof that growth can hold up after the Ansys-related integration and portfolio changes.
  • Negative Sentiment: The market may be weighing that Q2 EPS of $3.35 was still below the prior-year $3.67, which can temper enthusiasm even with a beat versus estimates. Zacks article

Synopsys Profile

(Free Report)

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.

See Also

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Synopsys Right Now?

Before you consider Synopsys, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.

While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks That Will Be Magnificent in 2026 Cover

Discover the next wave of investment opportunities with our report, 7 Stocks That Will Be Magnificent in 2026. Explore companies poised to replicate the growth, innovation, and value creation of the tech giants dominating today's markets.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines